PLK1 and neoplasm: Targeting PLK1 significantly inhibits cell proliferation, triggers cell cycle arrest, induces DNA damage and apoptosis in EOC cells, and suppresses tumor growth while prolonging survival in animal models of EOC (Zhang et al., 2015; Affatato et al., 2020; Valsasina et al., 2012; Wang et al., 2021; Noack et al., 2018; Gasimli et al., 2022).